Erle Mast Biography and Net Worth

Director of Zogenix

A member of our board of directors since May 2008, Mr. Mast has previous experience as a chief financial officer of various companies in the healthcare industry and in providing accounting, auditing and consulting services while at Deloitte & Touche, LLP. Mr. Mast was a co-founder of and served as Executive Vice President, Chief Financial Officer of Clovis Oncology, Inc. from May 2009 to March 2016. From July 2002 to May 2008, Mr. Mast served as Executive Vice President and Chief Financial Officer of Pharmion Corporation, until its acquisition by Celgene Corporation. From 2000 to 2002, after Elan Pharma International Ltd. acquired Dura Pharmaceuticals, Inc., Mr. Mast served as Chief Financial Officer for the Global Biopharmaceuticals business unit of Elan. From 1997 to 2000, Mr. Mast served as Vice President of Finance for Dura Pharmaceuticals. From 1984 to 1997, Mr. Mast held positions of increasing responsibility at Deloitte & Touche, LLP, serving most recently as Partner, where he provided accounting, auditing and business consulting services to companies in various industries, including the healthcare, pharmaceutical, biotech and manufacturing industries. Mr. Mast received a degree in Business Administration from California State University, Bakersfield.

What is Erle T. Mast's net worth?: The estimated net worth of Erle T. Mast is at least $80,760.36 as of November 26th, 2018. Mr. Mast owns 3,027 shares of Zogenix stock worth more than $80,760 as of April 23rd. This net worth estimate does not reflect any other assets that Mr. Mast may own. Learn More about Erle T. Mast's net worth.
How do I contact Erle T. Mast?: The corporate mailing address for Mr. Mast and other Zogenix executives is 5959 Horton Street Suite 500, EMERYVILLE CA, 94608. Zogenix can also be reached via phone at (510) 550-8300 and via email at [email protected]. Learn More on Erle T. Mast's contact information.
Has Erle T. Mast been buying or selling shares of Zogenix?: Erle T. Mast has not been actively trading shares of Zogenix in the last ninety days. Most recently, Erle T. Mast sold 1,250 shares of the business's stock in a transaction on Tuesday, February 1st. The shares were sold at an average price of $26.04, for a transaction totalling $32,550.00. Learn More on Erle T. Mast's trading history.
Who are Zogenix's active insiders?: Zogenix's insider roster includes Stephen Farr (President), Cam Garner (Director), Erle Mast (Director), and Renee Tannenbaum (Director). Learn More on Zogenix's active insiders.

Erle T. Mast Insider Trading History at Zogenix

Transaction Date	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
2/1/2022	Sell	1,250	$26.04	$32,550.00
1/19/2022	Sell	15,000	$26.09	$391,350.00
11/26/2018	Sell	1,468	$42.08	$61,773.44	3,027
12/11/2012	Buy	10,000	$1.15	$11,500.00

Erle T. Mast Buying and Selling Activity at Zogenix

Zogenix Company Overview

Zogenix, Inc. is a pharmaceutical company. The firm engages in the development and commercialization of central nervous system (CNS) therapies and products for the treatment orphan diseases and other CNS disorders. Its products include Fintepla and MT1621. The company was founded by Stephen James Farr, Cam L. Garner, Roger L. Hawley, Bret E. Megargel, Jonathan M. N. Rigby, Scott L. Glenn, and John J. Turanin on May 11, 2006 and is headquartered in Emeryville, CA.

Today's Range

Now: $26.68

$26.68

50 Day Range

MA: $26.52

$26.10

$26.68

2 Week Range

Now: $26.68

$11.03

$26.90

Volume

94 shs

Average Volume

3,764,363 shs

Market Capitalization

$1.50 billion

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.89

How to camouflage a factory of 53,000 workers

From Stansberry Research | Ad

Get the full story here.